0000899243-20-021492.txt : 20200805 0000899243-20-021492.hdr.sgml : 20200805 20200805174104 ACCESSION NUMBER: 0000899243-20-021492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20200805 DATE AS OF CHANGE: 20200805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zeldin Robert K CENTRAL INDEX KEY: 0001745347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38520 FILM NUMBER: 201078788 MAIL ADDRESS: STREET 1: C/O ACCELERON PHARMA INC. STREET 2: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MeiraGTx Holdings plc CENTRAL INDEX KEY: 0001735438 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 6464902965 MAIL ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-03 0 0001735438 MeiraGTx Holdings plc MGTX 0001745347 Zeldin Robert K 450 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 13.24 2020-08-03 4 A 0 150000 0.00 A 2030-08-02 Ordinary Shares 150000 150000 D The option vests as to one quarter of the total grant on August 3, 2021 and vests as to the remainder in 36 equal monthly installments thereafter. /s/ Robert K. Zeldin 2020-08-05